Prognostic value of functional tumor burden on 68Ga-DOTATOC PET/CT in patients with pancreatic neuro-endocrine tumors von Ohnona, J, Nataf, V, Gauthe, M, Balogova, S, Belissant Benesty, O, Zhang-Yin, J, Talbot, J N, Montravers, F

Volltext

Theranostic 64Cu-DOTHA2-PSMA for metastatic prostate cancer treatment, a preclinical study von Milot, M.C., Benesty, O. Bélissant, Dumulon-Perreault, V., Ait-Mohand, S., Rousseau, É., Richard, P., Guérin, B.

Volltext

64Cu-DOTHA2-PSMA, a Novel PSMA PET Radiotracer for Prostate Cancer with a Long Imaging Time Window von Milot, Marie-Christine, Benesty, Ophélie Bélissant, Dumulon-Perreault, Véronique, Ait-Mohand, Samia, Richard, Patrick O., Rousseau, Étienne, Guérin, Brigitte

Volltext

Theranostic 64Cu-DOTHA2-PSMA allows low toxicity radioligand therapy in mice prostate cancer model von Milot, Marie-Christine, Bélissant-Benesty, Ophélie, Dumulon-Perreault, Véronique, Ait-Mohand, Samia, Geha, Sameh, Richard, Patrick O., Rousseau, Étienne, Guérin, Brigitte

Volltext

64 Cu-DOTHA 2 -PSMA, a Novel PSMA PET Radiotracer for Prostate Cancer with a Long Imaging Time Window von Milot, Marie-Christine, Benesty, Ophélie Bélissant, Dumulon-Perreault, Véronique, Ait-Mohand, Samia, Richard, Patrick O, Rousseau, Étienne, Guérin, Brigitte

Volltext

Cu-DOTHA[sub.2]-PSMA, a Novel PSMA PET Radiotracer for Prostate Cancer with a Long Imaging Time Window von Milot, Marie-Christine, Benesty, Ophélie Bélissant, Dumulon-Perreault, Véronique, Ait-Mohand, Samia, Richard, Patrick O, Rousseau, Étienne, Guérin, Brigitte

Volltext

Theranostic 64 Cu-DOTHA 2 -PSMA allows low toxicity radioligand therapy in mice prostate cancer model von Milot, Marie-Christine, Bélissant-Benesty, Ophélie, Dumulon-Perreault, Véronique, Ait-Mohand, Samia, Geha, Sameh, Richard, Patrick O, Rousseau, Étienne, Guérin, Brigitte

Volltext